Skip to main content Back to Top
Advertisement

7/17/2019

Diclofenac Sodium 1% Topical Gel

Reason for the Shortage

    • Amneal has diclofenac 1% topical gel available.
    • Cipla USA has diclofenac 1% topical gel available.
    • Endo has Voltaren 1% topical gel available.
    • Par has diclofenac 1% topical gel available.

Available Products

    • Voltaren topical gel, Endo Pharmaceuticals, 1%, 100 gram tube, 1 count, NDC 63481-0684-47
    • Voltaren topical gel, Endo Pharmaceuticals, 1%, 20 gram tube, 1 count, NDC 63481-0684-83
    • Diclofenac sodium topical gel, Amneal, 1%, 100 gram tube, 1 count, NDC 65162-0833-66
    • Diclofenac sodium topical gel, Cipla USA, 1%, 100 gram tube, 1 count, NDC 69097-0524-44
    • Diclofenac sodium topical gel, Par Pharmaceuticals, 1%, 100 gram tube, 1 count, NDC 49884-0935-47

Updated

Updated July 17, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 14, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins